Palavra-chave: CHRONIC MYELOID LEUKAEMIA

BCR-ABL1 GENERIC IMATINIB NILOTINIB CYTOGENETIC RESPONSES RESPONSE TO SECOND-LINE SARS-COV-2 PHILADELPHIA CHROMOSOME-POSITIVE EXON 6 CML BCR-ABL HOCT1 THETA1 GSTT1 ANGIOGENESIS INHIBITOR GENE RUNX1 S-TRANSFERASE MU1 PERIPHERAL-BLOOD D-HPLC DASATINIB TYROSINE KINASE INHIBITORS SECOND-GENERATION GSTM1 POLYMORPHISMS IMATINIB VACCINES